Document is current
Any future updates will be listed below
-
Authors
Ekholm, Katja
Augustinsson, Annelie
Sundström, Johan
Johansen, Christian
Storgärds, Maria
Ljöstad, Lena
Taylan, Fulya
Ekblom, Eva
Juran, Stephanie
Ek, Marlene
Malmgren, Charlotta Ingvoldstad
Soller, Maria Johansson
Friedman, Mikaela
Thunström, Sofia
Lovmar, Lovisa
Nordgren, Ann
Ehrencrona, Hans
Lindstrand, Anna
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 20 October 2025
Accepted: 11 December 2025
First Online: 23 December 2025
Declarations
:
: JS, MS and CJ are direct or indirect shareholders of MinForskning AB, the legal entity supplying the eConsent system discussed in this article. JS also reports direct or indirect shareholdership in companies Anagram kommunikation AB, Sence Research AB, and Symptoms Europe AB, providing services to companies and authorities in the health sector including Amgen, AstraZeneca, Bayer, Boehringer, Eli Lilly, Gilead, GSK, Göteborg University, Itrim, Ipsen, Janssen, Karolinska Institutet, LIF, Linköping University, Novo Nordisk, Parexel, Pfizer, Region Stockholm, Region Uppsala, Sanofi, STRAMA, Takeda, TLV, Uppsala University, Vifor Pharma, WeMind. The other authors declare no conflicts of interest.
